Ischemic Neuroprotection by Insulin with Down-Regulation of Divalent Metal Transporter 1 (DMT1) Expression and Ferrous Iron-Dependent Cell Death

被引:0
作者
Fenaroli, Francesca [1 ]
Valerio, Alessandra [1 ]
Ingrassia, Rosaria [2 ]
机构
[1] Univ Brescia, Dept Mol & Translat Med, Sect Pharmacol, I-25123 Brescia, Italy
[2] Univ Brescia, Dept Mol & Translat Med, Sect Biotechnol, I-25123 Brescia, Italy
关键词
in vitro ischemia; insulin neuroprotection; oxygen glucose deprivation (OGD); divalent metal transporter 1 (DMT1); ferroptosis; neurodegeneration; BETA-CELLS; ISOFORMS; RECEPTOR;
D O I
10.3390/biom14070856
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The regulation of divalent metal transporter-1 (DMT1) by insulin has been previously described in Langerhans cells and significant neuroprotection was found by insulin and insulin-like growth factor 1 treatment during experimental cerebral ischemia in acute ischemic stroke patients and in a rat 6-OHDA model of Parkinson's disease, where DMT1 involvement is described. According to the regulation of DMT1, previously described as a target gene of NF-kB in the early phase of post-ischemic neurodegeneration, both in vitro and in vivo, and because insulin controls the NFkB signaling with protection from ischemic cell death in rat cardiomyocytes, we evaluated the role of insulin in relation to DMT1 expression and function during ischemic neurodegeneration. Methods: Insulin neuroprotection is evaluated in differentiated human neuroblastoma cells, SK-N-SH, and in primary mouse cortical neurons exposed to oxygen glucose deprivation (OGD) for 8 h or 3 h, respectively, with or without 300 nM insulin. The insulin neuroprotection during OGD was evaluated in both cellular models in terms of cell death, and in SK-N-SH for DMT1 protein expression and acute ferrous iron treatment, performed in acidic conditions, known to promote the maximum DMT1 uptake as a proton co-transporter; and the transactivation of 1B/DMT1 mouse promoter, already known to be responsive to NF-kB, was analyzed in primary mouse cortical neurons. Results: Insulin neuroprotection during OGD was concomitant to the down-regulation of both DMT1 protein expression and 1B/DMT1 mouse promoter transactivation. We also showed the insulin-dependent protection from cell death after acute ferrous iron treatment. In conclusion, although preliminary, this evaluation highlights the peculiar role of DMT1 as a possible pharmacological target, involved in neuroprotection by insulin during in vitro neuronal ischemia and acute ferrous iron uptake.
引用
收藏
页数:9
相关论文
共 37 条
  • [1] Late-onset Parkinsonism in NFκB/c-Rel-deficient mice
    Baiguera, Cristina
    Alghisi, Manuela
    Pinna, Annalisa
    Bellucci, Arianna
    De Luca, Maria Antonietta
    Frau, Lucia
    Morelli, Micaela
    Ingrassia, Rosaria
    Benarese, Marina
    Porrini, Vanessa
    Pellitteri, Michele
    Bertini, Giuseppe
    Fabene, Paolo Francesco
    Sigala, Sandra
    Spillantini, Maria Grazia
    Liou, Hsiou-Chi
    Spano, Pier Franco
    Pizzi, Marina
    [J]. BRAIN, 2012, 135 : 2750 - 2765
  • [2] The Expression of Insulin in the Central Nervous System: What Have We Learned So Far?
    Dakic, Tamara
    Jevdjovic, Tanja
    Lakic, Iva
    Ruzicic, Aleksandra
    Jasnic, Nebojsa
    Djurasevic, Sinisa
    Djordjevic, Jelena
    Vujovic, Predrag
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [3] Insulin/NFκB protects against ischemia-induced necrotic cardiomyocyte death
    Diaz, Ariel
    Humeres, Claudio
    Gonzalez, Veronica
    Teresa Gomez, Maria
    Montt, Natalia
    Sanchez, Gina
    Chiong, Mario
    Garcia, Lorena
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 467 (02) : 451 - 457
  • [4] FTO Inhibits Insulin Secretion and Promotes NF-κB Activation through Positively Regulating ROS Production in Pancreatic β cells
    Fan, Hong-Qi
    He, Wei
    Xu, Kuan-Feng
    Wang, Zhi-Xiao
    Xu, Xin-Yu
    Chen, Heng
    [J]. PLOS ONE, 2015, 10 (05):
  • [5] DISTRIBUTION OF I-125 FERROTRANSFERRIN BINDING-SITES IN THE MESENCEPHALON OF CONTROL SUBJECTS AND PATIENTS WITH PARKINSONS-DISEASE
    FAUCHEUX, BA
    HIRSCH, EC
    VILLARES, J
    SELIMI, F
    MOUATTPRIGENT, A
    JAVOYAGID, F
    HAUW, JJ
    AGID, Y
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 60 (06) : 2338 - 2341
  • [6] Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383
  • [7] Iron and infection
    Ganz, Tomas
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (01) : 7 - 15
  • [8] DMT1: A mammalian transporter for multiple metals
    Garrick, MD
    Dolan, KG
    Horbinski, C
    Ghio, AJ
    Higgins, D
    Porubcin, M
    Moore, EG
    Hainsworth, LN
    Umbreit, JN
    Conrad, ME
    Feng, L
    Lis, A
    Roth, JA
    Singleton, S
    Garrick, LM
    [J]. BIOMETALS, 2003, 16 (01) : 41 - 54
  • [9] Comparison of mammalian cell lines expressing distinct isoforms of divalent metal transporter 1 in a tetracycline-regulated fashion
    Garrick, Michael D.
    Kuo, Hung-Chieh
    Vargas, Farida
    Singleton, Steven
    Zhao, Lin
    Smith, Jaime J.
    Paradkar, Prasad
    Roth, Jerome A.
    Garrick, Laura M.
    [J]. BIOCHEMICAL JOURNAL, 2006, 398 : 539 - 546
  • [10] Cloning and characterization of a mammalian proton-coupled metal-ion transporter
    Gunshin, H
    Mackenzie, B
    Berger, UV
    Gunshin, Y
    Romero, MF
    Boron, WF
    Nussberger, S
    Gollan, JL
    Hediger, MA
    [J]. NATURE, 1997, 388 (6641) : 482 - 488